A phase II trial of neuroprotection with riluzole in early MS

Category Primary study
ConferenceAnnals of Neurology
Year 2013
This article has no abstract
Epistemonikos ID: 71c4c12df89165ab7d3dd02fbb56aab5730882ba
First added on: Apr 30, 2026